MedTrace Logo

Secur-Fit Advanced Outcomes Study

NCT01917929 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2025-07-23

Study results available
· View outcomes & findings →

Summary

The goal of this study is to evaluate the Secur-Fit Advanced Hip Stem in primary total hip replacement surgery.

Conditions

  • Arthroplasty, Replacement, Hip

Interventions

DEVICE

Secur-Fit Advanced Hip Stem

Straight femoral stem intended for cementless, press-fit application.

Sponsors & Collaborators

  • Stryker Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Edward Petrow, MD · Tucson Orthopaedic Institute

  • Geoffrey Westrich, MD · Hospital for Special Surgery, New York

  • Samuel Wellman, MD · Duke University

  • Paul Perona, MD · Family Orthopaedic Center

  • Michael Dayton, MD · University of Colorado, Denver

  • Thomas Bowen, MD · Geisinger Orthopaedic Institute

  • Frank Conguista, MD · Ortho NY

  • Michael Ast, MD · Mercer Bucks Orthopaedics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-15
Primary Completion
2023-05-01
Completion
2024-06-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917929 on ClinicalTrials.gov